Gout: why it flares, and how long-term treatment prevents it

A gout flare can feel like it came out of nowhere. Here's what is building up in the joint beforehand, and how a treat-to-target plan stops the cycle.

Written by Dr. Julia Buchfuhrer, DO, rheumatologist Last updated Sources cited Editorial policy
Gout and crystals7 min readPublished Updated

Key takeaways

  • Gout is caused by uric acid crystals that form in and around joints when uric acid stays high.
  • Flares are treated with colchicine, an NSAID or a steroid, ideally started early.
  • People with frequent flares, tophi or joint damage should be offered urate-lowering medicine.
  • The goal is a uric acid level below 6 mg/dL, reached step by step and kept there.

Gout is one of the most painful kinds of arthritis, and one of the most treatable. In the United States, about 9.2 million adults (3.9%) were living with gout in 2015–2016.[2] Yet many people only ever treat the flares, and never the cause.

What's happening in the joint

Uric acid is a normal waste product. When its level in the blood stays high for a long time, it can form tiny needle-shaped crystals of monosodium urate. These crystals settle quietly in and around joints, often for years, before the first flare.

A flare happens when the immune system suddenly reacts to those crystals. The joint becomes hot, red, swollen and exquisitely tender, often overnight. The big toe is the classic spot, but ankles, knees, wrists and fingers are common too.

Why flares happen

Anything that makes uric acid rise or fall quickly can trigger a flare. Common triggers include:

  • Alcohol, especially beer and spirits
  • Large meals rich in red meat, organ meats or shellfish
  • Sugary drinks sweetened with high-fructose corn syrup
  • Dehydration, illness or surgery
  • Some medicines, such as certain diuretics
  • Starting urate-lowering medicine without flare protection

Diet matters, but it is rarely the whole story. Genetics and kidney function play a large part in how well the body clears uric acid.

Treating a flare

The 2020 American College of Rheumatology (ACR) gout guideline strongly recommends colchicine, an NSAID or a glucocorticoid (steroid) as first-line treatment for a flare.[1] The choice depends on your kidneys, stomach, heart and other medicines. Treatment works best when started early, so many patients keep a flare plan at home. Ice and rest help too.

A flare is a symptom. The crystals are the disease. Treating only flares leaves the crystals in place.

Long-term treatment: treat to target

The same guideline strongly recommends urate-lowering therapy for people with one or more tophi (chalky crystal deposits), joint damage on imaging from gout, or frequent flares (two or more a year).[1] Key points:

  • Allopurinol is the preferred first medicine, including for people with moderate to severe chronic kidney disease.
  • Start low, go slow. The dose begins low and is raised gradually.
  • Aim for a uric acid level below 6 mg/dL, checked with regular blood tests while the dose is adjusted.
  • Protect against early flares with colchicine, an NSAID or a low-dose steroid for 3–6 months after starting.
  • Genetic testing (HLA-B*5801) is recommended before allopurinol for people of Southeast Asian descent and for African American patients, who have a higher risk of a rare, serious allergic reaction.

Once uric acid stays below target, crystals slowly dissolve. Flares become less frequent, and tophi can shrink. That's why the medicine is usually continued long-term, even when you feel well.

When to see a doctor

Contact the office if you've had more than one flare, have chalky lumps near your joints, or have kidney stones. A hot, swollen joint with fever or chills needs same-day care, because infection must be ruled out.

Call 911 for chest pain, trouble breathing, sudden vision loss, or a hot swollen joint with fever.

Sources and references

  1. FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Rheumatol. 2020;72(6):879-895. View source
  2. Chen-Xu M, Yokose C, Rai SK, et al. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007–2016. Arthritis Rheumatol. 2019;71(6):991-999. View source

About the author

Dr. Julia Buchfuhrer, DO

Board-certified rheumatologist and founder of JB Arthritis and Rheumatology Center in Downey, California. Special interest in gout and psoriatic arthritis.

Editorial policy

This article is general education for adults and is not a substitute for personal medical advice. Don't start, stop or change a medicine without talking to your doctor.

Keep reading

Lupus and autoimmune

Lupus: understanding a “great imitator”

Lupus can look like many other illnesses, and a positive ANA alone doesn't mean you have it. Here's how rheumatologists recognize and treat it.